Heeney JL - Search Results

1

Viruses as vaccine vectors for infectious diseases and cancer.

Draper SJ, Heeney JL. Draper SJ, et al. Among authors: heeney jl. Nat Rev Microbiol. 2010 Jan;8(1):62-73. doi: 10.1038/nrmicro2240. Nat Rev Microbiol. 2010. PMID: 19966816 Review.

2

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine.

Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, Pace M, Sernicola L, Koanga-Mogtomo ML, Betti M, Borsetti A, Belli R, Akerblom L, Corrias F, Buttò S, Heeney J, Verani P, Titti F, Ensoli B. Cafaro A, et al. Nat Med. 1999 Jun;5(6):643-50. doi: 10.1038/9488. Nat Med. 1999. PMID: 10371502

3

Immune imprinting and next-generation coronavirus vaccines.

Huang CQ, Vishwanath S, Carnell GW, Chan ACY, Heeney JL. Huang CQ, et al. Among authors: heeney jl. Nat Microbiol. 2023 Nov;8(11):1971-1985. doi: 10.1038/s41564-023-01505-9. Epub 2023 Nov 6. Nat Microbiol. 2023. PMID: 37932355 Review.

4

AIDS vaccine developments.

Osterhaus A, de Vries P, Heeney J. Osterhaus A, et al. Nature. 1992 Feb 20;355(6362):684-5. doi: 10.1038/355684b0. Nature. 1992. PMID: 1741054 No abstract available.

5

Infectious diseases: An ill wind for wild chimps?

Weiss RA, Heeney JL. Weiss RA, et al. Among authors: heeney jl. Nature. 2009 Jul 23;460(7254):470-1. doi: 10.1038/460470a. Nature. 2009. PMID: 19626107 No abstract available.

6

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge.

Negri DRM, Baroncelli S, Catone S, Comini A, Michelini Z, Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Mancini MG, Farcomeni S, Fagrouch Z, Ciccozzi M, Boros S, Liljestrom P, Norley S, Heeney J, Titti F. Negri DRM, et al. J Gen Virol. 2004 May;85(Pt 5):1191-1201. doi: 10.1099/vir.0.79794-0. J Gen Virol. 2004. PMID: 15105535

7

Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.

Krashias G, Simon AK, Wegmann F, Kok WL, Ho LP, Stevens D, Skehel J, Heeney JL, Moghaddam AE, Sattentau QJ. Krashias G, et al. Among authors: heeney jl. Vaccine. 2010 Mar 16;28(13):2482-9. doi: 10.1016/j.vaccine.2010.01.046. Epub 2010 Feb 2. Vaccine. 2010. PMID: 20132920

8

Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.

Osterhaus A, de Vries P, Morein B, Akerblom L, Heeney J. Osterhaus A, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1507-10. doi: 10.1089/aid.1992.8.1507. AIDS Res Hum Retroviruses. 1992. PMID: 1466991

9

A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen.

Davis D, Morein B, Akerblom L, Lövgren-Bengtsson K, van Gils ME, Bogers WM, Teeuwsen VJ, Heeney JL. Davis D, et al. Among authors: heeney jl. Vaccine. 1997 Oct;15(15):1661-9. doi: 10.1016/s0264-410x(97)00084-4. Vaccine. 1997. PMID: 9364697

10

The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection.

Heeney JL, van Gils ME, van der Meide P, de Giuli Morghen C, Ghioni C, Gimelli M, Raddelli A, Davis D, Akerblom L, Morein B. Heeney JL, et al. J Med Primatol. 1998 Apr-Jun;27(2-3):50-8. doi: 10.1111/j.1600-0684.1998.tb00226.x. J Med Primatol. 1998. PMID: 9747943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page